the pho view
DESCRIPTION
John Wilkinson. The PHO View. APHO. Cancer Registry. Core Funding Health Profiles Occasional Papers Website. PHINE. Drug & alcohol monitoring. Maternal & Infant Health. HES & Commissioning. Mental Health Observatory. National Library for Public Health. EU - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/1.jpg)
The PHO View
John Wilkinson
![Page 2: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/2.jpg)
APHO
Mental Health Observatory
Core FundingHealth ProfilesOccasional PapersWebsite
Drug &
alcohol monitoring
Maternal &
Infant Health
HES & Commissioning
National Library for Public Health
EU Commission
PHINECancer Registry
![Page 3: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/3.jpg)
Competency 5 – Manage knowledge and assess needs – some examples• Joint Strategic Needs Assessment • Health Profiles• SHAPE • Mental Health Observatory• Drugs and Alcohol• Cancer data• National Library for Public Health • Regional Maternity Survey Office:• HES Service• Europe
![Page 4: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/4.jpg)
Big Picture
• PHO delivers a number of non core functions
• Core functions now accounts for 25% of annual income
• More capacity and greater skill set in NEPHO
• PHINE
![Page 5: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/5.jpg)
National Library for Public Health
• Single source for evidence for public health workforce
• Evidence-based resources from around the world, UK policy and guidance, news & events, etc. www.library.nhs.uk/publichealth
![Page 6: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/6.jpg)
Drugs and alcohol
• Monthly (about 6 weeks after month end), quarterly and annual outputs to commissioners
• Used by DATs to commission, decommission and performance manage agencies
• Used by NTA and Healthcare Commission to manage whole system
• Alcohol data from April 2008 for PCTs
![Page 7: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/7.jpg)
Training and Development
NEPHO run workshops, teaching training and advice in
areas such as:
• The development of profiles, indicators performance measures and targets
• Health Needs Assessment• Health Equity Audit• Health Impact Assessment• Ethnic (and diversity) monitoring
![Page 8: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/8.jpg)
Example analysesNEPHO Life Expectancy reports
Trend in life expectancy at birth for males in South Tyneside
72
73
74
75
76
77
78
79
80
81
82
1995-1997 1996-1998 1997-1999 1998-2000 1999-2001 2000-2002 2001-2003 2002-2004 2003-2005
Life
exp
ecta
ncy
at b
irth
(yea
rs)
South Tyneside North East England Spearhead LAs
![Page 9: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/9.jpg)
Example analysesNEPHO Life Expectancy reports
L.E. at birth for males in South Tyneside, projected against target
69
70
71
72
73
74
75
76
77
78
79
80
1995
-199
7
1996
-199
8
1997
-199
9
1998
-200
0
1999
-200
1
2000
-200
2
2001
-200
3
2002
-200
4
2003
-200
5
2004
-200
6
2005
-200
7
2006
-200
8
2007
-200
9
2008
-201
0
2009
-201
1
Life
Exp
ecta
ncy
at B
irth
(Yea
rs)
South Tyneside ENGLAND Target trajectory Linear (South Tyneside) Linear (ENGLAND)
![Page 10: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/10.jpg)
Example analysesNEPHO Life Expectancy reports
Scenario modelling, males in South Tyneside
73
74
75
76
77
78
79
80
81
82
83
84
40%
redu
ction
incir
culat
ory d
eath
sat
ages
<75
20%
redu
ction
inca
ncer
mor
tality
atag
es <
75
20%
redu
ction
inac
ciden
t mor
tality
at al
l age
s
20%
redu
ction
insu
icide
at al
l age
s
All fo
ur ta
rget
s
Life
Exp
ecta
ncy
at B
irth
(Yea
rs)
PSA target for England (2009/2011) = 78.6 years
South Tyneside target (2009/2011) = 77.0 years
South Tyneside 2003/2005 = 74.8 years
![Page 11: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/11.jpg)
Mental Health - Discharge to first contact
•Key indicator of post-discharge follow up
•Important for suicide prevention
•Collected through the Mental Health Minimum Dataset
•Data shown are for 2005/6
•Available in the NEPHO Mental Health Workbook
![Page 12: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/12.jpg)
Interval between discharge and first clinical contact(Patients of all ages - 2005/6)
England
0%
10%
20%
30%
40%
50%
60%
70%
80%
Mental Health Local Implementation Areas
Prop
ortio
n of
pat
ient
s co
ntac
ted
By 27th day
By 20th day
By 13th dayBy 6th day
North East
0%
10%
20%
30%
40%
50%
60%
70%
80%
Darlin
gton
Co. Dur
ham
Hartle
pool
Gatesh
ead
Redca
r and
Cleve
land
Stock
ton
Middles
brou
gh
South
Tynes
ide
Newca
stle
North
Tynesid
e
Northu
mberla
nd
Sunde
rland
![Page 13: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/13.jpg)
RMSO data
J un-05Mar-03Dec-00Sep-98J un-96Mar-94Dec-91Sep-89Jun-87Mar-85
0.0012
0.0010
0.0008
0.0006
0.0004
0.0002
0.0000
Quarter
Rate
11
Rate of gastroschisis by quarter of LMP
![Page 14: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/14.jpg)
![Page 15: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/15.jpg)
Europe
• “We want our region to perform best of all the regions in Europe” (SE Coast - Darzi Report)
Percentage of obese persons
0
5
10
15
20
25
Régions
% o
f obe
se p
erso
ns
Germany United-Kingdom Austria Belgium Spain France Luxembourg Netherlands
Sweden Estonia Hungary Latvia Malta 1st quartile 3rd quartile Median
Source: ISARE Data Set
![Page 16: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/16.jpg)
SHAPE
![Page 17: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/17.jpg)
Local ProvisionAdmissions to Trusts for PCT A (2004/05)
60.9%
11.8%
11.5%
7.5%
4.6%
1.2%
0.3% 0.3%
0.8%
0.2%0.1%
0.1%
0.7% Trust 1 Trust 2
Trust 3 Trust 4
Trust 5 Trust 6
Trust 7 Trust 8
Trust 9 Trust 10
Trust 11 Trust 12
OTHER
![Page 18: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/18.jpg)
High Volume Emergency HRGs and ALOS
HRG35 HRG LabelNat
ALOS Trust1 Trust2 Trust3 Trust4 Trust51 E36 Chest Pain <70 w/o cc 1.62 1.13 1.40 1.11 0.69 3.672 F47 General Abdominal Disorders <70 w/o cc 2.36 1.90 2.87 2.41 2.94 0.833 P03 Upper Respiratory Tract Disorders 0.88 0.63 1.31 0.80 1.69 0.174 M09 Threatened or Spontaneous Abortion 0.57 0.46 0.82 0.62 0.00 5 S16 Poisoning, Toxic, Environmental and Unspecified 1.96 1.43 1.07 1.26 0.73 0.006 P13 Other Gastrointestinal or Metabolic Disorders 1.49 1.10 1.62 1.14 3.03 7 D40 COPD or Bronchitis w/o cc 7.39 6.76 5.37 6.55 0.008 E35 Chest Pain >69 or w cc 3.49 2.44 3.76 2.21 1.00 0.759 P06 Minor Infections (including Immune Disorders) 1.44 0.84 1.00 1.23 2.44 1.67
10 P26 Infectious and Non-Infectious Gastroenteritis 1.07 0.76 1.50 0.88 2.79 1.0011 E12 Acute Myocardial Infarction w/o cc 7.53 6.56 7.97 6.31 4.00 7.7512 D99 Complex Elderly with a Respiratory System P.D 16.63 16.18 15.75 11.88 2.0013 F46 General Abdominal Disorders >69 or w cc 6.13 4.64 5.15 3.85 7.59 1.5014 D41 Unspecified Acute Lower Respiratory Infection 9.6 9.49 6.12 7.83 5.75 9.0015 E31 Syncope or Collapse >69 or w cc 7.65 6.66 6.70 5.90 8.67 3.0016 E22 Ischaemic Heart Disease without intervention 6.32 3.66 4.78 3.23 3.50 13.0017 P01 Asthma or Wheezing 1.24 0.81 1.21 1.25 2.00 18 E29 Arrhythmia or Conduction Disorders >69 or w cc 7.32 5.49 5.96 5.64 3.67 10.0019 L09 Kidney or Urinary Tract Infections >69 or w cc 13.97 13.23 10.80 8.24 7.50 5.0020 E23 IHD without intervention <70 w/o cc 3.67 2.77 3.09 2.41 1.00 2.50
![Page 19: The PHO View](https://reader033.vdocuments.net/reader033/viewer/2022051518/56815da3550346895dcbcc80/html5/thumbnails/19.jpg)
Future?
• PHINE• PCT chief executives development group• What support is needed?• What could we do better?• What could we do less of?